Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Iconovo AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | SEK 9.10 |
52 Week High | SEK 24.90 |
52 Week Low | SEK 7.46 |
Beta | 0.78 |
11 Month Change | -12.50% |
3 Month Change | 14.90% |
1 Year Change | -60.94% |
33 Year Change | -88.39% |
5 Year Change | -83.45% |
Change since IPO | -74.72% |
Recent News & Updates
Recent updates
We're A Little Worried About Iconovo's (STO:ICO) Cash Burn Rate
Jul 06Here's Why We're Watching Iconovo's (STO:ICO) Cash Burn Situation
Jul 29Companies Like Iconovo (STO:ICO) Are In A Position To Invest In Growth
Nov 10We're Not Worried About Iconovo's (STO:ICO) Cash Burn
Jul 31Is Now The Time To Look At Buying Iconovo AB (publ) (STO:ICO)?
Jul 12Iconovo AB (publ)'s (STO:ICO) Intrinsic Value Is Potentially 37% Above Its Share Price
Jun 13Companies Like Iconovo (STO:ICO) Can Afford To Invest In Growth
Apr 13When Will Iconovo AB (publ) (STO:ICO) Turn A Profit?
Mar 18Have Iconovo AB (publ) (STO:ICO) Insiders Been Selling Their Stock?
Feb 20A Look At Iconovo's (STO:ICO) Share Price Returns
Feb 07Have Insiders Been Buying Iconovo AB (publ) (STO:ICO) Shares?
Dec 21Shareholder Returns
ICO | SE Medical Equipment | SE Market | |
---|---|---|---|
7D | 4.6% | 3.2% | 3.0% |
1Y | -60.9% | 0.7% | 17.7% |
Return vs Industry: ICO underperformed the Swedish Medical Equipment industry which returned 3.2% over the past year.
Return vs Market: ICO underperformed the Swedish Market which returned 18.4% over the past year.
Price Volatility
ICO volatility | |
---|---|
ICO Average Weekly Movement | 8.3% |
Medical Equipment Industry Average Movement | 8.3% |
Market Average Movement | 5.9% |
10% most volatile stocks in SE Market | 12.4% |
10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: ICO's share price has been volatile over the past 3 months.
Volatility Over Time: ICO's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2013 | 29 | Johan Waborg | www.iconovo.se |
Iconovo AB (publ) develops and licenses inhalation medications in Sweden. The company offers ICOres, a flexible multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler; and ICOone Nasal single-dose dry powder inhaler for nasal use. It serves generic companies.
Iconovo AB (publ) Fundamentals Summary
ICO fundamental statistics | |
---|---|
Market cap | SEK 144.86m |
Earnings (TTM) | -SEK 39.03m |
Revenue (TTM) | SEK 22.56m |
6.4x
P/S Ratio-3.7x
P/E RatioIs ICO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ICO income statement (TTM) | |
---|---|
Revenue | SEK 22.56m |
Cost of Revenue | SEK 7.39m |
Gross Profit | SEK 15.17m |
Other Expenses | SEK 54.20m |
Earnings | -SEK 39.03m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 24, 2024
Earnings per share (EPS) | -2.45 |
Gross Margin | 67.23% |
Net Profit Margin | -172.99% |
Debt/Equity Ratio | 0% |
How did ICO perform over the long term?
See historical performance and comparison